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Summary.-Several methods of ascertaining and classifying childhood neoplasms
for epidemiological study have been evaluated using material from the University
of Manchester Children's Tumour Registry (CTR), which includes data from several
sources on children with neoplasms first seen in the period 1954-73 who were under
15 years old and living in the Manchester Regional Hospital Board area at the
time.
Two systems of classification-the International Classification of Diseases (ICD)
and the Morphology Section of the Manual of Tumor Nomenclature and Coding
(MOTNAC; Percy, Berg and Thomas, 1968)-were tested. No major problems arose
with the Morphology Section of MOTNAC, and we recommend that the revised
version of this section, in the proposed "International Classification of Diseases for
Oncology", should beusedinepidemiological reportsonchildren'stumours whenever
possible. The ICD discriminates less well between the commoner types of childhood
neoplasms, but must be retained as a supplementary classification to facilitate
international comparisons.
A comparison of the completeness of ascertainment achieved in recent years by
each source of data showed that more than 98% of the serious cases (neoplasms that
were malignant and/or laywithinthecraniovertebralcanal)couldhavebeenidentified
using a combination of Hospital Activity Analysis (HAA) and cancer registration
records, and more than 95% using HAA and death records. But in an analysis of
2 years' HAA returns and 6 years' cancer registrations of serious cases, nearly one
quarter of the former and one fifth of the latter were shown to record diagnoses
which differed from those finally assigned at the CTR. It is concluded that, in
epedimiological studies based on routine records, the diagnoses given should always
be checked centrally, by experts, in the light of all the available clinical and patho-
logical material (including histological preparations).
Several recent moves to promote and
link epidemiological studies of childhood
neoplasms in this and other countries have
underlined the need to standardize classi-
fication and to determine which sources of
ascertainment are the most efficient.
Students of childhood neoplasms have
tended in the past to develop their own
systems of classification, and although
some of these have been adapted from
internationally accepted standards such
as the International Classification of Dis-
eases (ICD) and the Manuatl of Tumor
*Dr Steward died on 20 June 1975.
NomenclatureandCoding(MOTNAC;Percy
et al., 1968), a diversity has resulted which
creates problems when attempts are made
either to compare differentworkers' figures
with one another or to relate them to data
classified entirely by one of the standard
systems (as most routine cancer statistics
are). Incomplete or inaccurate ascertain-
ment also makes comparisons difficult,
since its completeness or accuracy may
vary between groups so as to mask or
mimic real differences in incidence caused
by aetiological factors.I. LECK, J. M. BIRCH, H. B. MARSDEN AND J. K. STEWARD
Until recently, most cases of childhood
cancer could be ascertained from death
registrations, and these have been the
only source of ascertainment used in
many major studies (e.g. Stewart, Webb
and Hewitt, 1958; Miller, 1969, 1971), but
as treatment has improved this source has
become less complete, and the above-
quoted workers and others have recently
been using various other records of
children seen at hospital with cancer, as
well as death registers, to ascertain cases
(e.g. Hinds, Wilson and Draper, 1974;
Hanawa, 1975; Young and Miller, 1975).
Few, if any, attempts have been made to
quantify the completeness or accuracy of
these other sources, although there have
been studies of the adequacy of death
registration data (e.g. Heasman and
Lipworth, 1966; Alderson and Meade,
1967).
A useful instrument for evaluating the
other sources that are now generally
available to British workers is provided by
the University of Manchester Children's
Tumour Registry (CTR), which includes
all known cases presenting from 1954
onwards in a child population of about
one million in North-Western England
(Marsden and Steward, 1968). The final
diagnosis in all these cases has been made
by a small group of experts in children's
tumour pathology, in the light of all the
available clinical and pathological data
(including histological preparations of
solid tumours and blood films from
patients with leukaemia). In this com-
munication, we assess the completeness
and accuracy of the generally available
sources of data on children's tumours by
comparing data from these sources with
the Registry's own. We also report
analyses carried out on the latter data to
test the applicability to children's tumours
of ICD and MOTNAC.
MATERIAL AND METHODS
The 1954-73 records of the University of
Manchester CTR relate to children with
leukaemia and solid tumours (other than
benign pigmented naevi, haemangiomata and
polypi) who were first seen by clinicians or
pathologists during this period and who
were under 15 years old and lived in the
Manchester Regional Hospital Board area at
the time. Cases have been ascertained
mainly by direct notification from clini-
cians and pathologists, who have been
encouraged to collaborate by personal con-
tact, but registrations of deaths and cancer
cases and Hospital Activity Analysis records
of inpatients in the study area have also been
searched for cases.
Death registrations mentioning neoplasms
in children resident in the study area were
traced for all the years studied, although the
ways in which this was done varied. More
than half the period was covered by examin-
ing the records of the Regional Cancer
Registry (RCR) for the study area and the
Oxford Survey of Childhood Cancers, which
between them had already been sent parti-
culars of all these and certain other death
registrations for the years 1961-73 by the
Office of Population Census and Surveys
(OPCS) or the General Register Office which
preceded it. Complete data for earlier years
had not already been supplied, but we made
up this deficiency from (a) a list of relevant
1959-60 deaths which the OPCS provided
using its computer system, and (b) the
copies of death registrations formerly sent to
Medical Officers of Health in respect of
deceased residents of their areas, which were
examined for deaths in 1954-58.
All cases of cancer seen at hospitals in the
study area have been registrable since the
beginning of 1962 under the National
Cancer Registration Scheme (NCRS) for
England and Wales. Such patients are
notified to the RCR by the medical records
departments of the hospitals. As already
indicated, the RCR is also notified of cancer
deaths by the OPCS. When a death record
is received in respect of a cancer patient who
has not been reported to the RCR by any
hospital, further information is sought from
the hospital where the patient was treated
or from his general practitioner. Cases
notified to the RCR are all registered under
the NCRS if they involve malignant neo-
plasms of any site (or benign neoplasms
within the craniovertebral canal) accordingto
the most reliable source from which data were
obtained (hospital, general practitioner, or
death register). Summaries of all registra-
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tions are sent from the RCR to the OPCS,
and in both places there are sets of punch
cards containing data such as the diagnosis
ofeach case (classified both histologically and
according to the TCD). The coding and
punching of these data were done at the
OPCS for the 1962-67 cases, and at the RCR
for more recent years. The cancer registra-
tions for 1962-71 that related to children
were identified by sorting these cards.
Punch cards for the 1972-73 registrations
were not yet available, so the original
1972-73 registration forms were gone through
twice by hand to find those relating to
children.
Hospital Activity Analysis (HAA, another
national scheme) involves the collection of
data on all hospital inpatients apart from
those in maternity and psychiatric hospitals,
and has been in operation throughout the
study area (except in Furness, which has
only just over 2% of the area's population)
since the beginning of 1972. When an
inpatient leaves hospital, data includino the
case-note number and diagnosis (or diagnoses
if more than one is considered relevant) are
abstracted from the case-notes by a clerk and
perhaps a member of the medical staff.
The data are coded locally (each diagnosis
being given its ICD code number) and then
sent as computer input to the Regional
Health Authority. From this source, com-
puter printouts were obtained of the HAA
records that appeared to relate to children
under 15 admitted to hospital with any kind
of neoplasm between January 1972 and
March 1974 inclusive. Although the print-
outs did not give the children's names, one
could check whether most of them were
known already to the CTR by comparing
the case-note numbers listed on the printouts
-with those in CTR and NCRS records.
Following the ascertainment of a case
from any of the above sources, one of us
(usually JKS) examined the original case
notes (or in a few cases transcripts from
them). Blood films were also inspected in
cases reported to have leukaemia, and in
those with other neoplasms we were generally
able to obtain histological sections of the
lesion, which w--ere always examined by
another of us (HBM) and in most cases by an
international panel of specialists in tumour
pathology as well. In every case ascertained
during the period covered by this report, the
final decisions as to tumour type and eligi-
bilitv for the CTR series have been taken
jointly by the same two workers (HBM and
JKS) in the light of all this clinical and
pathological evidence.
RESULTS
Classification
The Eighth Revision of ICD and the
Morphology Section of MOTNAC were
both tested by using them to classify the
CTR cases first seen in the period 1954-68
in respect of final diagnosis. The 1969-73
TABLE I. Nu,mbers of Neoplasm8 in Children's Tutmour Registry (CTR) Series Diagnosed
in 1954-68, by ICD Category (Eighth Revision)
Category of neoplasm (ICD)
Code numbers
Malignant Bei-ign etc.
170 213; 232.0
171 214; 215; 232.1
189 223.0-2; 223. 8-9;
237.3-5; 237.9
190 224; 238.0
191 225.0; 238.1
192 225.1-9; 238.2- 9
200-202
204-207; 209
Rest of Rest of 210-239
140-209
Other
Total
DeJsuriptioii
Bone
Connective and other soft tissue
Urinary organs (excluding
bladlder)
Eye
Brain
Other parts of nerx-ous system
Lymphoid tisslue
Leukaemia
Other condlitions in ICD,
Ch. II
Conditions in AMOTNAC but
not ICD, Ch. II
Numbers of rieoplasms
AMalignanit Benign etc. Total
79
65
88
53
266
135
111
455
107
18
25
1
0
15
23
0
0
97
97
90
89
53
281
158
111
455
204
0 19 19
1359 198 1557
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TABLE II. Numbers ofNeoplasms in CTRSeries Diagnosed in 1954-68, by Morphological
Group (MOTNAC)
Morphological group (MOTNAC)
Code numbers Description
880 892 Muscular and connective tissue
893-899 Complex mixed and stromal
906-909 Germ cell and teratomatous
918-926 Bone
938-948 Gliomatouis
949-952 Neuroepitheliomatous
980-993 Leukaemic
959-975 Other lymphoid and
Rest of 800-999
Total
haematopoietic
Other types in MOTNAC
Fibromata of bone (in ICD,
Ch. II but not in MOTNAC)
Numbers of neoplasms
AMalignant Benign etc. Total
91 27 118
92 3 95
18 43 61
69 11 80
248 39 287
156 10 166
466 0 466
100 0 100
76
0
1:316
102
6
178
6
241 1557
cases were not included because the test
was carried out before finalizing the
diagnoses of these cases.
The distribution of cases by ICD
category is summarized in Table I.
Separate columns of figures are given for
malignant and other neoplasms. The
figures for the malignant group show how
many cases there were in each three-digit
category or group of categories ofthe ICD
that included many childhood cases, and
in all other categories combined. More
than 4000 of the malignant neoplasms
arose in lymphoid or haematopoietic
tissue, and more than 3000 in the nervous
system, including the eye. The benign
neoplasms (and those of doubtful malig-
nancy) are shown classified to the same
sites as the malignant, with an additional
category to accommodate conditions listed
as non-neoplastic by the ICD although
classed as neoplasms by MOTNAC (e.g.
endocrine adenomata, von Reckling-
hausen's disease). Far fewer benign than
malignant tumours are included, but our
ascertainment of the former is likely to
have been very incomplete, since unless
they lie within the craniovertebral canal
they seldom endanger life and are not
registrable under the NCRS.
A summary of the figures obtained
when cases were classified according to the
Morphology Section of MOTNAC is given
in Table II. This classification has 61
main categories. In the table two ofthese
(gliomatous andneuroepitheliomatous neo-
plasms) appear as separate entries. With
two exceptions (bone fibromata not in
MOTNAC and miscellaneous neoplasms),
each ofthe other entries comprises several
adjacent categories of MOTNAC com-
bined-e.g. fibromatous, myxomatous,
lipomatous and myomatous neoplasms,
and sarcomas not further defined, here
grouped together as muscular and con-
nective tissue neoplasms. Forty-three
fewer cases are listed as malignant in
Table II than in Table I, largely because
most ependymomata are classified by
MOTNAC as of doubtful malignancy and
by ICD as malignant; but neoplasms of
lymphoid, haematopoietic and nervous
tissues preponderated to much the same
extent among those classified as malignant
by the two systems.
The relationship of ICD category to
morphological type is explored in Table
III, which shows the cases distributed
according to both classifications. There
was a fairly close correspondence between
the two in that over 70o ofthe neoplasms
in each of the 8 ICD categories that
included many cases were of one morpho-
logical class or group of classes. For
example, 940o ofneoplasms in the urinary
organs (excluding thebladder)wereWilms'
tumours (in the complex mixed and
stromal group); 94% in the brain were
gliomata; and 98% in the eye and 72%
in " other parts of nervous system " were
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retinoblastomata and neuroblastomata re-
spectively(bothclassifiedasneuroepithelio-
matous). The lymphoid and haemato-
poietic tissue groups defined by the 2
classifications were the same except for 11
cases of leucosarcoma (listed among the
lymphomata in ICD and among the
leukaemias in MOTNAC).
Completeness of ascertainment
The completeness of the notifications
of cases reaching the CTR direct from
hospital consultants and via the RCR (the
latter including all cases identifiable from
death registrations) could only be com-
TABLE IV. Numbers of Conditions Diagrn
Registered with the Regional Cancer Regist
Scheme and/or Notifie
Registration particulars
Neoplasms eligible for NCRS registration
Registered with RCR and notified direct to CTR:
Death registration received
Death registration not received
Registered with RCR but not notified direct to CTI
Death registration received
Death registration not received
Not registered with RCR but notified direct to CTR
Total
Conditions not eligible for NCRS registration
Registered with RCR but not notified direct to CTI
Death registration received
Death registration not received
Not registered with RCR but notified direct to CTfI
(valid CTR cases only)
Total
pared in respect of patients first seen in
the period 1971-73, since it had not been
recorded whether those seen earlier had
been notified in both ways independently.
HAA data were only available for the
1972-73 period.
The numbers of 1971-73 cases ascer-
tained from the sources available through-
out this period (other than cases notified
to the CTR but neither accepted to be
neoplastic nor known to the RCR) are
shown in Table IV. These cases included
339 that were eligible for NCRS registra-
tion with the RCR, and 48 that were not.
Ofthe 339, 9400 (including 490 for whom
wosed in Children in 1971-73 which were
ry under the National Cancer Registration
?d Direct to the CTR
Neoplasms of
lymphoid and
haematopoietic Other
tissue conditions Total
75 81 156
76 68 144
6 3 9
3 8 11
5 14 19
165 174 339
1 2 3
1 16 17
0 28 28
2 46 48
TABLE V. Children with Neoplasms in CTR Series Diagnosed in 1972-73 (Excluding
Those Not Registrable Under the NCRS)Classified according to whether Records of Their
Admission to Hospitals with any Neoplassms were found in Hospital Activity Analysis
Files for January 1972-March 1974
Hospital Activity Analysis findings
Neoplasms notified to RCR and/or to CTR direct:
Spell in registering hospital eligible for HAA:
In HAA file of regist3ring hospital
In HAA file of other hospital only
Not found in any HAA file
Care by registering agency not eligible for HAA:
In HAA file of other hospital
Not found in any HAA file
Neoplasms not notified to RCR or to CTR direct:
Found in HAA file
Total
Neoplasms of
lymphoid and
haematopoietic
tissue
97
2
5
4
3
0
111
Other
neoplasms
101
6
8
1
7
3
126
Total
198
8
13
5
10
3
237
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death registration particulars had been
received) had been so registered and 9400
had been notified direct to the CTR. The
48 cases ineligible for registration with the
RCR comprised 28 that had been notified
to the CTR alone with benign tumours,
and 20 registered under the NCRS but
found on further enquiry to be of benign
neoplasms (6) or non-neoplastic conditions
(10) or to involve non-residents of the
study area (4).
The completeness of the HAA data for
all known 1972-73 cases that were eligible
for NCRS registration is examined in
Table V. From a total of 237 cases 219
had been notified to the RCR or CTR by a
hospital where they had received inpatient
treatment for which there should have
been an HAA record, but in 21 of the 219
this record was not found. Apart from
these 219 cases there were 15 whose care
by the notifying agency was outside the
scope of HAA (5 inpatients of hospitals
outside the Regional Health Authority's
HAA catchment area, 8 outpatients, 1
nursing home case, and 1 general practi-
tioner's) and 3 who were included in HAA
without having been notified to the RCR
or CTR. The total number of cases for
whom HAA records were found was 214
(90%o), including 13 cases in which the
hospital(s) where the HAA records origi-
nated did not include the source of the
RCR or CTR notification.
The amount of overlap between all
the sources from which the 1972-73 cases
were ascertained is examined in more
detail in Tables VI and VII and the
Figure. Table VI shows the distribution
obtained when the 237 1972-73 cases were
split simultaneously into those found and
not found in the HAA file (shown in
different columns) and into those notified
and not notified to the RCR and/or direct
to the CTR (shown on different rows as in
Table IV). Table VII may be considered
in 3 parts. In the first, we have used the
data for 1971-73 in Table IV (supple-
mented by the percentage of cases ascer-
tained from HAA alone in 1972-73-1.3o%)
to estimate the percentages of cases that
might be ascertained from each source and
combination of sources other than HAA
and from none (column b). Secondly we
have used data from Table VI to estimate
what proportion of the cases in each of
these ascertainment categories might have
been ascertained using HAA data alone
(column e). Thirdly, in columns f and g
respectively, we have multiplied each of
the percentages in column b by the
corresponding proportion in column e and
by the difference between the latter
proportion and unity, to obtain estimates
of the percentages of all cases that might
be ascertained from every possible com-
bination of the sources of data used.
These percentages are also given in the
TABLE VI.-Numbers of Neoplasms in CTR Series Diagnosed in 1972-73 (Excluding
those not Registrable under the ANCRS) by Source of Ascertainment
Neoplasms of
lymphoid and
haematopoietic
tissue Other neoplasms Total
In HAA Not in In HAA Not in In HAA Not in
Registration particulars file HAA file file HAA file file HAA file
Registered with RCR and notified direct to CTR
Death registration received
Death registration not received
Registered with RCR but not notified direct to CTR
46 2 45 7* 91 9*
52 2 45 3 97 5
Death registration received 3 2 2 0 5 2
Death registration not received 2 0 5 2* 7 2*
Not registered with RCR but notified direct to CTR 0 2 1 1 3 1 l 5
Not registered with RCR nor notified direct to CTR 0 3 3
Total 103 8 111 15* 214 23*
* Including two NCRS registrations (one also notifiedldirect to CTR and the otherinot) ofcases seen at
local NHS hospitals not participating in HAA.
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FIG.-Percentages of childhood neoplasms (of types registrable under the National Cancer Regis-
tration Scheme) that might be ascertained from different sources (from Table VII).
Figure. They confirm that for complete-
ness of ascertainment there was little to
choose between HAA records (which
included 91% of known cases), RCR
registrations (93%), and notifications to
the CTR from consultants (93%). Between
98% and 99% of the cases could have
been ascertained given any two of these
three sources, and more than 95% if
merely the sources not special to neo-
plasms (death registration and HAA) had
been available.
Diagnostic accuracy of cancer registry data
To assessthe accuracy ofdata collected
under the NCRS, the morphology code
numbers entered in NCRS files were com-
pared with the final CTR diagnoses for all
cases in the CTR series which had been
registered under the NCRS for 1963-68.
Morphological type was examined in
preference to ICD category because in
childhood neoplasms it is the more infor-
mative. 1963 was the first year for which
the NCRS morphology data were suffi-
ciently detailed and 1968 was the last for
which all cases had been assigned a final
CTR diagnosis at the time of the enquliry.
In about 9% ofthe cases, the morpho-
logical type in NCRS records differed
enough from the final CTR diagnosis to
fall into a different group ofthe simplified
morphological classification used in Table
II, but in more than half these cases the
difference was only between a more and a
less precise diagnosis orbetweenleukaemia
and another lymphoreticular neoplasm
(Table VIII). The effect which these
discrepancies had on the overall distribu-
tion of cases between categories of the
simplified classification is shown in more
detail in Table UI, which gives the addi-
tions and subtractions needed to convert
the NCRS distribution to what was correct
according to the CTR.
In addition to these errors, there were
i77I. LECK, J. M. BIRCH, H. B. MARSDEN AND J. K. STEWARD
TABLE VIII.-Neoplasms in the CTR Series that were Registered under the National
Cancer Registration Scheme in 1963-68, Classified According to whether they were
Assigned to Categories in the Same Morphological Groups (Table II) by Both Agencies
Consistency of sources
Placed in same group by CTR and NCRS
Type uncertain (in " other " group) in CTR; not in " other " group in NCRS
Not in " other " group in CTR; type uncertain (in " other " group) in NCRS
" Leukaemic " in CTR; " other lymphoid and haematopoietic" in NCRS
" Other lymphoid and haematopoietic " in CTR; " leukaemic" in NCRS
Embryonal myosarcoma (in " muscular and connective tissue" group) in
CTR; specific types in other groups in NCRS
Other discrepancies
Total
Number
480
10
8
6
3
7
Percentage
90 7
19
1-5
1.1
0 6
1*3
15 2-8
529 100
TABLE IX.-Morphological Distribution of Neoplasms in the CTR Series that were
Registered under the National Cancer Registration Scheme in 1963-68
Distribution by group Distribution by group
according to NCRS according to CTR ~~~~~~~A
NCRS group NCRS group
Morphological group (MOTNAC) Total incorrect incorrect Total
Muscular and connective tissue 34 - 3 + 9 - 40
Complex mixed and stromal 30 - 2 + 2 30
Germ cell and teratomatous 7 - 1 + 1 7
Bone 16 - 2 + 1 = 15
Gliomatous 114 - 0 + 8 = 122
Neuroepitheliomatous 48 - 5 + 2 = 45
Leukaemic 178 - 4 + 7 = 181
Other lymphoid and haematopoietic 57 - 15 + 4 - 46
Other 45 - 17 + 15 43
Total 529 - 49 + 49 = 529
TABLE X.-MJorphological Distribution of Leukaemia Cases in the CTR Series that were
Registered as Leukaemia by the National Cancer Registration Scheme in 1963-68
Morphological group (MOTNAC)
Code number Description
980 Leukaemia, NOS
982 Lymphocytic leukaemia
984 Erythroleukaemia
986 Granulocytic leukaemia
989 Monocytic leukaemia
Total
of course cases in which the morphological
type given in NCRS records differed in
detail from the final diagnosis but was in
the same group ofthe simplified classifica-
tion. As an example of discrepancies of
this kind, Table X shows that in 30% of
the 174 cases diagnosed as leukaemia by
both sources in Table IX, the cell type in
the final CTR diagnosis differed from that
recorded under the NCRS.
Diagnostic accuracy of Hospital Activity
Analysis data
The only diagnostic data given in HAA
Distribution by type
according to NCRS
A
NCRS type
Total incorrect
33 - 8 -
99 - 28
1 - 1 -
37 - 15
4
174
- 20 4
52 -4
Distribution by type
according to CTR
NCRS type
incorrect Total
- 38 - 63
- 10 = 81
- 0 = 0
3 = 25
- 1 = 5
- 52 = 174
records are ICD code numbers, which we
have therefore compared with the final
CTR diagnoses (coded in the same way)
for all the 214 cases registrable under the
NCRS for which HAA data were available.
In 50 (23%) ofthese cases, the 3-digit code
number given for HAA was not fully
appropriate to the final diagnosis (Table
XI). The discrepancies resembled those
found when the NCRS diagnoses were
analysed (Table VIII) in that more than
half involved cases in which one diagnosis
was merely more precise than the other, or
in which the problem was one of dis-
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TABLE XI.-Neoplasms in the CTR Seriesfor 1972-73 that were Also Found in Hospital
Activity Analysis Files, Classified According to whether they were Assigned to the
Same Three-digit Diagnostic Categories of the International Classification of Disease
by Both Agencies
Consistency of sources
Placed irn same category by CTR and HAA
Lymphosarcoma (200) in one source; lymphatic leukaemia (204) in other
Leukaemia specified as lymphoid (204) or myeloid (205) in one source but of
undefined cell type (207) in other
Neoplasms of brain (191) in one source; of central nervous system not further
defined (192) in other
Neoplasm assigned to same site in both sources, but malignant (140-199)
in one and benign or unspecified (210-239) in other
Other discrepancies
Total
Number Percentage
164
4
11
76-6
1 *9
5 -1
12 5*6
9 4-2
14 6-5
214 100
TABLE XII.-Distribution by Category (Based on the International Classification of
Disease) of Neoplasms in the CTR Series for 1972-73 that were Also Found in Hospital
Activity Analysis Files
Category of neoplasm (ICD)
Malignant neoplasms
Bone
Connective an(l other soft tissue
Urinary organs (excluding bladder)
Eye
Brain
Other parts of nervous system
Lymphoid tissue
Leukaemia
Other
Benign or unspecifiedl neoplasms
Nervous system
Other
Total
Distribution by category Distribution by category
according to HAA according to CTR
HAA group HAA group
Total incorrect incorrect Total
12
4
14
3
28
23
21
80
21
4
4
214
tinguishing between different lymphoid
and haematopoietic neoplasms.
In 38 ofthe 50 discrepancies, the HAA
and CTR diagnoses were in different
categories ofthe short classification (based
on the ICD) that we used in Table I. The
distribution of these cases is examined in
Table XII.
DISCUSSION
Classification
Our trial of the ICD and the Morpho-
logy Section of MOTNAC leads us to
prefer the latter for studies of the epi-
demiology and pathology of children's
tumours. The ICD splits neoplasms pri-
6
3
3
0
_1
12
4
7
3
3
38
+ -v
+
+
+
+
+
+
+
±
+
0
3
0
0
15
1
3
4
8
1
3
38
9
4
14
2
42
12
20
83
22
2
4
214
marily into malignant, benign, and of
unspecified malignancy. A few of the
categories in these main groups relate to
specific tissues (e.g. lipoma, malignant
melanoma) but most to specific anatomical
sites. This defining of most cancers in
terms of site fits the ICD for use where
histological data are not available. Its
use in aetiological studies of adult cancers
can also be justified on the grounds that at
almost every site that is commonly
affected in this age group the vast majority
of cases are of carcinoma, and that locally
acting extrinsic factors which differ very
much from site tio site probably play a
major part in the aetiology of these cases.
Most childhood neoplasms however arise
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at sites lesslikely tobeaffectedbylocalized
extrinsic factors; and the cancers that
occur relatively frequently in children at
some of these sites (or at sites that are
grouped together by the ICD) are of more
than one type. For example, Ewing's
tumour and osteosarcoma are both cancers
of bone (ICD category no. 170). Simi-
larly, neuroblastomata of sympathetic
ganglia are assigned on the basis of site to
the same 3-digit category as meningeal
and spinal cord malignancies (" 192:
malignant neoplasm of other parts of
nervous system ") in the current ICD (the
8th Revision), and have recently been
grouped with soft tissue sarcomas under
" 171: malignant neoplasm of connective
andother soft tissue " bythe International
Conference for the 9th Revision of the
ICD.
The Morphology Section of MOTNAC
classifies primarily by histogenesis, and
subdivides the groups so defined into
malignant, benign, and of doubtful malig-
nancy. It includes separate categories
for all the tumour types mentioned in the
last paragram,ph (even though for brevity
they have been grouped with others in the
abbreviated form of this classification
used above-e.g. in Table II), and our use
ofit to classify childhood neoplasms raised
no major problems. We have a few reser-
vations about its nomenclature (e.g. its
use ofthe term " lymphocytic leukaemia"
for lymphoid leukaemia-which in chil-
dren is not generally lymphocytic but
lymphoblastic); but a revised and ex-
panded version in which some of these
anomalies (including the example quoted)
have been corrected has recently been
prepared, and is now undergoing field
trials as part of an " International Classi-
fication of Diseases for Oncology " which
it is intended to publish as a supplement to
the ICD (9th Revision). The contents of
the MOTNAC-based categories listed in
Tables II and IX would have been the
same if. the revised Morphology Section
had been used, except that bone fibromata
and cases of Letterer-Siwe's disease would
have been included (under " bone " and
" other lymphoid and haematopoietic"
respectively).
As the revised Morphology Section has
all the merits of the original, and is in
addition likely to become the standard
classification based on histogenesis for
neoplasms at all ages, we recommend that
this should be the main classification used
in studies of children's tumour pathology
and epidemiology whenever possible, and
that any demands for a more detailed
classification should in general be met by
subdividing existing categories ratherthan
by developing a whole new system.
Bearing in mind, however, that for most
communities the only available data relate
to cases analysed by ICD category, we
consider that, to facilitate international
comparisons, the distribution of cases by
ICD category as well as by morphology
shouldbegiveninreports onthefrequency
of childhood neoplasms in large series.
Although the ICD discriminates less well
than the Morphology Section ofMOTNAC
between the commoner types of childhood
neoplasms, several of these (notably
Wilms' tumour, retinoblastoma, and the
lymphoid and haematopoietic neoplasms)
are practically specific to ICD categories
which include hardly any childhood cases
of other neoplasms (Table III). One
might therefore hope to detect any
marked variations in the frequency of
these tumour types by comparing the
incidence of or mortality from neoplasms
ofthe related sites.
Completeness ofascertainment
The distribution of our cases between
sources (Tables VI and VII and Figure)
suggests that practically all children who
presented with life-threatening neoplasms
in the period 1972-73 were ascertained.
Even in HAA records, the least productive
ofour 3 main sources, 91% ofthe 1972-73
cases of neoplasms registrable under the
NCRS and known to any of the 3 sources
were identified. A further 7% are found
when HAA and NCRS records (the least
productive pair of sources) are both used,
and addition of the third source (notifica-
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tions to the CTR from clinicians) only
contributes 2% more. The latter figure
is not quite as low as one would expect it
to be ifthe first 2 sources were independent
(in which case only 05%0* of all 1972-73
cases would be expected to be missed by
both); in other words, cases notified to one
of these agencies appear-not surprisingly
-to be more likely than other cases to be
notified to the other agency also, and in
these circumstances the level of ascertain-
ment achieved using data from both is
likely to be lower than ifthe agencies were
independent. Nevertheless, the diminish-
ing returns seen when one source is supple-
mented by a second and then by a third
strongly suggest that if more sources still
were to be added, the yield offurther cases
would be negligible.
Ifour inference that virtually all severe
cases diagnosed in the period 1972-73
were ascertained is correct, we can use the
proportions ofcases in this series that were
ascertained from routine sources as esti-
mates ofthe proportions ofall severe cases
that might be so ascertained. These
estimates amount to more than 98% for
ascertainment from cancer and death
registrations and HAA records, and more
than 95%0 if cancer registration data for
survivors are excluded. From the first of
these figures we conclude that in areas
where all hospitals participate in both
HAA and NCRS (or in similar schemes),
a high enough level of ascertainment of
children's cancer for most epidemiological
purposes may be achieved by considering
merely children who had neoplasms ac-
cording to either or both of these sources.
The estimate that ascertainment from
death registrations and HAA would be
95%0 complete suggests that the ending of
cancer registration as a separate hospital
activity which has already happened in
Wales so far as inpatients are concerned,
following the introduction of HAA (West,
1973) would make little difference to the
completeness of ascertainment that is
possible from routine sources. The com-
pleteness of one of the two remai.ning
sources of this kind--death registration-
is of course being eroded by advances in
treatment, but there is scope for the
other HAA to rise above its level for
1972-73, when nearly 10% of the patients
notified to the RCR or CTR from HAA
hospitals to which they had been admitted
had no HAA record of admission to these
hospitals with neoplasms (Table V).
Omissions of this kind should become
rarer as the hospitals to which HAA was
new in 1972 acquire more experience of
the system, and it is also to be hoped that
HAA will eventually be extended to cover
outpatient as well as inpatient episodes,
and to include all hospitals in the country
in one standardized system, the benefits
of which would include access by each
Health Authority to data on members of
its population who are treated elsewhere.
If HAA had had these features in 1972-73,
all but 2 ofthe cases undergoing " care by
registering agency not eligible for HAA'
(Table V) might have been included (the
exceptions being the nursing home's case
and the general practitioner's), which
would have added more than 30% to the
proportion of all registrable children's
neoplasms ascertained from HAA. Given
these improvements, it should therefore be
possible to identify a high enough propor-
tion of children with cancer for most
epidemiological purposes, merely by scan-
ning HAA and death records.
Accuracy of ascertainment
Although almost all cases of childhood
cancer can apparently be identified from
routine sources, our findings strongly
suggest that the diagnostic data available
from these sources are inadequate. From
the expert review of all the available
clinical and pathological findings carried
out in every case for the CTR, it seems that
nearly 60/ ofthe cases registered under the
NCRS in 1971-73 were not eligible for
*Lb. (+b+c+ b)], where a an(d b are the numbers of cases fotun(d in the records of HAA bult, not
NCRS anid( of NCRS buit Inot HAA respectively, an(d c is the number commoin to both souirces.
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this registration (Table IV); thatin nearly
one fifth of the eligible cases registered in
1963-68, the NCRS coding and the final
CTR diagnosis in terms of morphology
either fell into different categories of our
simplified classification (Tables VIII and
IX) or at least-in cases agreed to have
leukaemia-differed in cell type (TableX);
and that nearly a quarter of the eligible
cases first seen in 1972-73 for whom
entries were found in HAA files had not
been assigned there to the 3-digit ICD
categories most appropriate to them
(Tables XI and XII). Admittedly, some
of these discrepancies may be regarded as
trivial; some may have been due to
inexperience, since the 1963-68 and 1972-
73 data were collected when cancer regis-
tration and HAA respectively were rela-
tively new to the hospitals concerned; and
in some cases there may have been room
for more than one opinion as to the correct
diagnosis. Nevertheless, the magnitude
of the discrepancies forces us to conclude
that although purely routine records may
be used to identify children with cancer,
the diagnoses they record should not be
accepted unquestioningly in any epide-
miological study of childhood neoplasia,
local or national. Instead, they should
always be reviewed by experts in the light
of the case notes and (if possible) histo-
logical preparations. To promote con-
sistency in this procedure, the reviewers
should ifpossible be the same throughout
the survey, since there are some issues-
e.g. whether certain cases ofleukaemia are
of lymphoid or undefined (blast cell) type
-on which even expert observers not
infrequently differ. As well as yielding
useful epidemiological information, a re-
gister of childhood neoplasms compiled in
this way can provide an excellent base for
clinical and laboratory research.
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